219 related articles for article (PubMed ID: 9693251)
21. Intravesical oxybutynin chloride: experience with 42 patients.
Weese DL; Roskamp DA; Leach GE; Zimmern PE
Urology; 1993 Jun; 41(6):527-30. PubMed ID: 8516987
[TBL] [Abstract][Full Text] [Related]
22. Long-term intravesical oxybutynin chloride therapy in children with myelodysplasia.
Painter KA; Vates TS; Bukowski TP; Fleming P; Freedman AL; Smith CA; Gonzalez R; Perlmutter AD
J Urol; 1996 Oct; 156(4):1459-62. PubMed ID: 8808907
[TBL] [Abstract][Full Text] [Related]
23. Intravesical application of a stable oxybutynin solution improves therapeutic compliance and acceptance in children with neurogenic bladder dysfunction.
Buyse G; Verpoorten C; Vereecken R; Casaer P
J Urol; 1998 Sep; 160(3 Pt 2):1084-7; discussion 1092. PubMed ID: 9719281
[TBL] [Abstract][Full Text] [Related]
24. Topical oxybutynin chloride for relaxation of dysfunctional bladders.
Brendler CB; Radebaugh LC; Mohler JL
J Urol; 1989 Jun; 141(6):1350-2. PubMed ID: 2724432
[TBL] [Abstract][Full Text] [Related]
25. [Combination of oxybutynin chloride (Ditropan) with intermittent catheterization in the treatment of neurogenic bladder in childhood: results on continence].
De Castro R; Casolari E; Ricci S
Pediatr Med Chir; 1984; 6(6):795-803. PubMed ID: 6545593
[TBL] [Abstract][Full Text] [Related]
26. Combined intravesical and oral oxybutynin chloride in adult patients with spinal cord injury.
Pannek J; Sommerfeld HJ; Bötel U; Senge T
Urology; 2000 Mar; 55(3):358-62. PubMed ID: 10699610
[TBL] [Abstract][Full Text] [Related]
27. Can Oral Fesoterodine Be an Alternative for Intravesical Oxybutynin Instillations in Children with Neuropathic Bladder Dysfunction?
van den Heijkant M; De Coster K; Jansen K; Bogaert G
Urol Int; 2019; 103(2):202-210. PubMed ID: 31117096
[TBL] [Abstract][Full Text] [Related]
28. Complications of intravesical oxybutynin chloride therapy in the pediatric myelomeningocele population.
Palmer LS; Zebold K; Firlit CF; Kaplan WE
J Urol; 1997 Feb; 157(2):638-40. PubMed ID: 8996387
[TBL] [Abstract][Full Text] [Related]
29. Postpubertal urodynamic and upper urinary tract changes in children with conservatively treated myelomeningocele.
Almodhen F; Capolicchio JP; Jednak R; El Sherbiny M
J Urol; 2007 Oct; 178(4 Pt 1):1479-82. PubMed ID: 17706702
[TBL] [Abstract][Full Text] [Related]
30. Effects of oxybutynin on vesicoureteral reflux in children.
Homsy YL; Nsouli I; Hamburger B; Laberge I; Schick E
J Urol; 1985 Dec; 134(6):1168-71. PubMed ID: 4057409
[TBL] [Abstract][Full Text] [Related]
31. Urodynamic parameters development and complications of clean intermittent self-catheterization in Chinese schoolchildren with neurogenic underactive bladder.
Wang QW; Song DK; Zhang XP; Wu YD; Zhang RL; Wei JX; Wen JG
Urol Int; 2011; 86(4):461-5. PubMed ID: 21555862
[TBL] [Abstract][Full Text] [Related]
32. An extended-release formulation of oxybutynin chloride for the treatment of overactive urinary bladder.
Goldenberg MM
Clin Ther; 1999 Apr; 21(4):634-42. PubMed ID: 10363730
[TBL] [Abstract][Full Text] [Related]
33. [Topical administration of oxybutynin hydrochloride in women with urge incontinence. Results of a prospective randomized double-blind study].
Enzelsberger H; Kurz C; Helmer H; Mittermayer F
Geburtshilfe Frauenheilkd; 1995 May; 55(5):240-3. PubMed ID: 7607378
[TBL] [Abstract][Full Text] [Related]
34. Propiverine compared to oxybutynin in neurogenic detrusor overactivity--results of a randomized, double-blind, multicenter clinical study.
Stöhrer M; Mürtz G; Kramer G; Schnabel F; Arnold EP; Wyndaele JJ;
Eur Urol; 2007 Jan; 51(1):235-42. PubMed ID: 16698176
[TBL] [Abstract][Full Text] [Related]
35. Urodynamic effects and safety of modified intravesical oxybutynin chloride in patients with neurogenic detrusor overactivity: 3 years experience.
Saito M; Watanabe T; Tabuchi F; Otsubo K; Satoh K; Miyagawa I
Int J Urol; 2004 Aug; 11(8):592-6. PubMed ID: 15285747
[TBL] [Abstract][Full Text] [Related]
36. [Value of intravesically instilled oxybutynin in refractory bladder hyperactivity. Study of 15 cases].
Amarenco G; Adba MA; Kerdraon J
Prog Urol; 1992; 2(4):660-3. PubMed ID: 1302108
[TBL] [Abstract][Full Text] [Related]
37. Effect of controlled-release oxybutynin on neurogenic bladder function in spinal cord injury.
O'Leary M; Erickson JR; Smith CP; McDermott C; Horton J; Chancellor MB
J Spinal Cord Med; 2003; 26(2):159-62. PubMed ID: 12828295
[TBL] [Abstract][Full Text] [Related]
38. Intravesical oxybutynin for neurogenic bladder dysfunction: less systemic side effects due to reduced first pass metabolism.
Buyse G; Waldeck K; Verpoorten C; Björk H; Casaer P; Andersson KE
J Urol; 1998 Sep; 160(3 Pt 1):892-6. PubMed ID: 9720583
[TBL] [Abstract][Full Text] [Related]
39. Intravesical instillation of oxybutynin hydrochloride for detrusor hyper-reflexia.
O'Flynn KJ; Thomas DG
Br J Urol; 1993 Nov; 72(5 Pt 1):566-70. PubMed ID: 10071538
[TBL] [Abstract][Full Text] [Related]
40. Clinical reevaluation of the effect of oxybutynin chloride on uninhibited neurogenic and reflex neurogenic bladder.
Kawabe K; Abe S; Kanda T; Tei K
Urol Int; 1986; 41(1):16-20. PubMed ID: 3962017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
